← Oncology Approval Tracker

FDA DECISION ·

Paclitaxel protein-bound particles (HBT)

paclitaxel protein-bound particles (albumin-bound) · HBT Labs

FDA approvalNew formulationBreast, lung and pancreatic cancer
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Albumin-bound paclitaxel suspension for specified metastatic breast cancer after prior treatment, initial advanced NSCLC in combination with carboplatin, and first-line metastatic pancreatic adenocarcinoma with gemcitabine.

LAMPGEN ANALYSIS

Why it matters

The product decision covers an albumin-bound formulation across three established treatment settings.

What research teams should watch

Verify the formulation, indication-specific schedule, and partner drug before substituting paclitaxel products.

PRIMARY RECORDS

Sources